MedTrace Logo

Tolerability of Iron Therapy in Women With AUB

NCT04915196 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-06-07

No results posted yet for this study

Summary

Telephone surveys of female patients using liposomally-bound iron and traditional iron sulphate preparations for the management of iron deficiency anemia to determine gastrointestinal tolerability.

Conditions

Interventions

DIETARY_SUPPLEMENT

Liposomally-bound Iron

Ferric pyrophosphate microencapsulated in liposomal form is an over the counter natural health product approved by Health Canada and commonly used for iron replacement. If this product is prescribed as part of usual management of iron deficiency and patients consent to participation they will be contacted by telephone survey of gastrointestinal tolerability.

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Chandrew Rajakumar, M.D. · University of Calgary

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-07-01
Completion
2022-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04915196 on ClinicalTrials.gov